Understanding Histological Transformation in EGFR-positive NSCLC
Tyrosine kinase inhibitors (TKIs) are a class of drugs used to treat patients with certain types of advanced-stage non-small cell lung cancer (NSCLC). Each TKI targets cancer cells
Tyrosine kinase inhibitors (TKIs) are a class of drugs used to treat patients with certain types of advanced-stage non-small cell lung cancer (NSCLC). Each TKI targets cancer cells
In the past few years, immunotherapies, or treatments that leverage the body’s natural immune system to fight disease, have emerged as an exciting treatment option for advanced
Immunotherapy, the treatment that harnesses the body’s natural defenses to fight disease, has helped patients, excited imaginations, and stimulated new avenues of research in lung
When Laura Petrillo, MD, meets an advanced-stage lung cancer patient for the first time, she begins by explaining what she does. As a palliative care physician at Massachusetts
This information has been reviewed and endorsed by members of LUNGevity Foundation’s Scientific Advisory Board. Please see our COVID-19 Vaccine FAQs page for more questions and
Over the past several years, Jeffrey Thompson, MD, MS, watched eagerly as checkpoint inhibitors, immunotherapy drugs that take the brakes off the immune system to allow the body to
For many decades, chemotherapy, despite the side effects it can cause, was the standard of care for advanced-stage lung cancer patients. While every patient does not benefit from
Caregiving and the word burden are often put together, however, this is an unfortunate coupling of words. Cancer is a burdensome disease, the healthcare system is complex and
Historically, lung cancer surgeries were all thoracotomies, or what are considered “open procedures,” during which the ribs are spread and the chest wall is cut in order to access
In this video brought to you in collaboration with Johnson & Johnson, Andrea Ferris, CEO and President of LUNGevity, and Avrum Spira, MD, MSc, Global Head of the Lung Cancer
Immunotherapy, the treatment approach that harnesses the body’s natural immune system to fight disease, has become an important option for patients with advanced-stage lung cancer
Vaccines are an area full of promise for lung cancer patients. A big difference between the lung cancer vaccines being developed and a common existing vaccine, the flu shot, is